A Trial to Investigate the Effectiveness of Testosterone Treatment in Men With Multiple Sclerosis
Status:
Withdrawn
Trial end date:
2099-01-01
Target enrollment:
Participant gender:
Summary
This is a multicenter, prospective, placebo-controlled, double-blind randomized Phase II
clinical trial assessing the effect of testosterone treatment vs. placebo treatment for 96
weeks duration on whole brain atrophy in men with MS.